Impact of Oncogenic Targets by Tumor-Suppressive
Base Sequence
Cell Line, Tumor
Cell Movement
/ genetics
Cell Proliferation
/ genetics
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Head and Neck Neoplasms
/ genetics
Humans
MicroRNAs
/ genetics
Neoplasm Invasiveness
Neoplasm Proteins
/ genetics
Oncogenes
RNA, Messenger
/ genetics
Signal Transduction
/ genetics
Squamous Cell Carcinoma of Head and Neck
/ genetics
GNA12
HNSCC
OLR1
expression signature
miR-139-3p
miR-139-5p
microRNA
passenger strand
tumor suppressor
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
14 Sep 2021
14 Sep 2021
Historique:
received:
16
08
2021
revised:
11
09
2021
accepted:
12
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
25
2
2023
Statut:
epublish
Résumé
We newly generated an RNA-sequencing-based microRNA (miRNA) expression signature of head and neck squamous cell carcinoma (HNSCC). Analysis of the signature revealed that both strands of some miRNAs, including
Identifiants
pubmed: 34576110
pii: ijms22189947
doi: 10.3390/ijms22189947
pmc: PMC8469660
pii:
doi:
Substances chimiques
MIRN139 microRNA, human
0
MicroRNAs
0
Neoplasm Proteins
0
RNA, Messenger
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Japan Society for the Promotion of Science
ID : 19H03847, 19K09863, 19K18759, 20H03883, and 21K09577
Références
N Engl J Med. 2016 Nov 10;375(19):1856-1867
pubmed: 27718784
Cell Prolif. 2017 Aug;50(4):
pubmed: 28464433
N Engl J Med. 2020 Jan 2;382(1):60-72
pubmed: 31893516
Nat Rev Drug Discov. 2017 Mar;16(3):203-222
pubmed: 28209991
Nucleic Acids Res. 2008 Jan;36(Database issue):D149-53
pubmed: 18158296
Nat Commun. 2020 Feb 20;11(1):968
pubmed: 32080184
J Cell Mol Med. 2017 Dec;21(12):3730-3740
pubmed: 28780773
Mol Oncol. 2020 Feb;14(2):426-446
pubmed: 31755218
Oncol Rep. 2019 Nov;42(5):1699-1708
pubmed: 31485677
Elife. 2015 Aug 12;4:
pubmed: 26267216
Cancer Sci. 2017 Aug;108(8):1681-1692
pubmed: 28612520
Nat Genet. 2005 May;37(5):495-500
pubmed: 15806104
Cancer Metastasis Rev. 2017 Sep;36(3):525-545
pubmed: 28836104
Onco Targets Ther. 2018 Sep 27;11:6295-6304
pubmed: 30310293
Clin Cancer Res. 2017 Jul 15;23(14):3884-3895
pubmed: 28143871
J Hum Genet. 2018 Dec;63(12):1197-1210
pubmed: 30228364
PLoS One. 2013 Jun 07;8(6):e66133
pubmed: 23762476
Br J Pharmacol. 2009 Sep;158(1):41-9
pubmed: 19226283
Oncotarget. 2014 Oct 30;5(20):9626-40
pubmed: 25275299
Lancet Oncol. 2010 Jan;11(1):21-8
pubmed: 19897418
Nat Rev Cancer. 2018 May;18(5):269-282
pubmed: 29497144
Oncotarget. 2016 Nov 1;7(44):72084-72098
pubmed: 27765924
Nat Rev Cancer. 2021 Jan;21(1):22-36
pubmed: 33082563
Nat Rev Clin Oncol. 2018 Sep;15(9):541-563
pubmed: 29784926
Mol Cancer Res. 2020 May;18(5):685-697
pubmed: 32019809
J Immunother Cancer. 2019 Jul 15;7(1):184
pubmed: 31307547
Oncotarget. 2017 Jul 26;8(41):70097-70115
pubmed: 29050264
Biomedicines. 2020 Dec 12;8(12):
pubmed: 33322675
Oncotarget. 2017 May 2;8(18):30288-30304
pubmed: 28415821
Int J Mol Sci. 2019 Sep 11;20(18):
pubmed: 31514295
Oncotarget. 2017 Dec 11;9(3):3663-3676
pubmed: 29423074
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
J Hum Genet. 2020 Nov;65(11):1019-1034
pubmed: 32623445
Cancer Sci. 2018 Sep;109(9):2919-2936
pubmed: 29968393
Pathol Res Pract. 2020 Nov;216(11):153194
pubmed: 32916448
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
Cells. 2019 Nov 28;8(12):
pubmed: 31795200
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Exp Clin Cancer Res. 2021 Jan 21;40(1):35
pubmed: 33478586
Br J Cancer. 2017 Jul 25;117(3):409-420
pubmed: 28641312
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
Int J Oncol. 2018 Jan;52(1):166-178
pubmed: 29115582
Oncol Lett. 2017 Aug;14(2):1215-1222
pubmed: 28789336
J Biochem. 2011 Oct;150(4):357-69
pubmed: 21873336
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
Auris Nasus Larynx. 2018 Aug;45(4):854-865
pubmed: 29233721
Lancet. 2019 Jan 12;393(10167):156-167
pubmed: 30509740
Cancer Lett. 2017 Nov 1;408:60-70
pubmed: 28844714
Int J Mol Sci. 2020 Sep 04;21(18):
pubmed: 32899691
Front Biosci (Landmark Ed). 2020 Jun 1;25:1732-1745
pubmed: 32472755
Cancer Sci. 2016 Sep;107(9):1233-42
pubmed: 27355528